Compare Eli Lilly And Co (LLY) vs Invesco Preferred ETF (PGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Invesco Preferred ETF — how do they compare? Eli Lilly And Co trades at $1,214.24 (market cap $1.08T), while Invesco Preferred ETF trades at $10.64. The key difference: Eli Lilly And Co pays a 0.57% dividend while Invesco Preferred ETF pays none. Which is the better fit depends on your goals.
| LLY | PGX | |
|---|---|---|
Market Cap | $1.08T | — |
Sector | Health | — |
52-Week High | $1.24K | $11.87 |
52-Week Low | $639.43 | $10.65 |
Enterprise Value | $1.13T | — |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Invesco Preferred ETF
The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.
Read more on PGX →
